ANC 0 3 0 3 B-clinical_variable
≥1000/µL 4 12 4 12 O

Aspartate 0 9 13 22 B-clinical_variable
aminotransferase 10 26 23 39 I-clinical_variable
/ 26 27 39 40 I-clinical_variable
serum 27 32 40 45 I-clinical_variable
glutamic 33 41 46 54 I-clinical_variable
- 41 42 54 55 I-clinical_variable
oxaloacetic 42 53 55 66 I-clinical_variable
transaminase 54 66 67 79 I-clinical_variable
( 67 68 80 81 I-clinical_variable
AST 68 71 81 84 I-clinical_variable
/ 71 72 84 85 I-clinical_variable
SGOT 72 76 85 89 I-clinical_variable
) 76 77 89 90 I-clinical_variable
, 77 78 90 91 O
alanine 79 86 92 99 B-clinical_variable
aminotransferase 87 103 100 116 I-clinical_variable
/ 103 104 116 117 I-clinical_variable
serum 104 109 117 122 I-clinical_variable
glutamic 110 118 123 131 I-clinical_variable
- 118 119 131 132 I-clinical_variable
pyruvic 119 126 132 139 I-clinical_variable
transaminase 127 139 140 152 I-clinical_variable
( 140 141 153 154 I-clinical_variable
ALT 141 144 154 157 I-clinical_variable
/ 144 145 157 158 I-clinical_variable
SGPT 145 149 158 162 I-clinical_variable
) 149 150 162 163 I-clinical_variable
, 150 151 163 164 O
and 152 155 165 168 O
gamma 156 161 169 174 B-clinical_variable
- 161 162 174 175 I-clinical_variable
glutamyltransferase 162 181 175 194 I-clinical_variable
( 182 183 195 196 I-clinical_variable
GGT 183 186 196 199 I-clinical_variable
) 186 187 199 200 I-clinical_variable
≤2.5 188 192 201 205 O
xupper 193 199 206 212 I-upper_bound
limit 200 205 213 218 I-upper_bound
of 206 208 219 221 I-upper_bound
normal 209 215 222 228 I-upper_bound
( 216 217 229 230 I-upper_bound
ULN 217 220 230 233 I-upper_bound
) 220 221 233 234 I-upper_bound
( 222 223 235 236 O
AST 223 226 236 239 O
/ 226 227 239 240 O
ALT 227 230 240 243 O
/ 230 231 243 244 O
GGT 231 234 244 247 O
≤5 235 237 248 250 O
xULN 238 242 251 255 I-upper_bound
if 243 245 256 258 O
documented 246 256 259 269 O
hepatic 257 264 270 277 O
involvement 265 276 278 289 O
with 277 281 290 294 O
lymphoma 282 290 295 303 B-cancer
) 290 291 303 304 O

Creatinine 0 10 305 315 B-clinical_variable
≤2.0 11 15 316 320 O
mg 16 18 321 323 I-upper_bound
/ 18 19 323 324 I-upper_bound
dL 19 21 324 326 I-upper_bound
or 22 24 327 329 O
calculated 25 35 330 340 B-clinical_variable
creatinine 36 46 341 351 I-clinical_variable
clearance 47 56 352 361 I-clinical_variable
≥50 57 60 362 365 O
mL 61 63 366 368 I-lower_bound
/ 63 64 368 369 I-lower_bound
min 64 67 369 372 I-lower_bound

Eastern 0 7 373 380 B-clinical_variable
Cooperative 8 19 381 392 I-clinical_variable
Oncology 20 28 393 401 I-clinical_variable
Group 29 34 402 407 I-clinical_variable
( 35 36 408 409 I-clinical_variable
ECOG 36 40 409 413 I-clinical_variable
) 40 41 413 414 I-clinical_variable
performance 42 53 415 426 I-clinical_variable
status 54 60 427 433 I-clinical_variable
≤2 61 63 434 436 O

Females 0 7 437 444 B-gender
of 8 10 445 447 O
childbearing 11 23 448 460 O
potential 24 33 461 470 O
are 34 37 471 474 O
to 38 40 475 477 O
agree 41 46 478 483 B-contraception_consent
to 47 49 484 486 I-contraception_consent
practice 50 58 487 495 I-contraception_consent
a 59 60 496 497 I-contraception_consent
medically 61 70 498 507 I-contraception_consent
acceptable 71 81 508 518 I-contraception_consent
contraceptive 82 95 519 532 I-contraception_consent
regimen 96 103 533 540 I-contraception_consent
( 104 105 541 542 O
including 105 114 542 551 O
a 115 116 552 553 O
barrier 117 124 554 561 B-contraception_consent
method 125 131 562 568 I-contraception_consent
) 131 132 568 569 O
from 133 137 570 574 O
study 138 143 575 580 B-treatment
treatment 144 153 581 590 I-treatment
initiation 154 164 591 601 O
until 165 170 602 607 O
at 171 173 608 610 O
least 174 179 611 616 O
30 180 182 617 619 B-lower_bound
days 183 187 620 624 I-lower_bound
after 188 193 625 630 O
the 194 197 631 634 O
last 198 202 635 639 O
administration 203 217 640 654 O
of 218 220 655 657 O
Folotyn 221 228 658 665 B-treatment
or 229 231 666 668 O
leucovorin 232 242 669 679 B-treatment
, 242 243 679 680 O
whichever 244 253 681 690 O
is 254 256 691 693 O
last 257 261 694 698 O
, 261 262 698 699 O
and 263 266 700 703 O
are 267 270 704 707 O
to 271 273 708 710 O
have 274 278 711 715 O
a 279 280 716 717 O
negative 281 289 718 726 B-pregnancy
urine 290 295 727 732 I-pregnancy
beta 296 300 733 737 I-pregnancy
human 301 306 738 743 I-pregnancy
chorionic 307 316 744 753 I-pregnancy
gonadotropin 317 329 754 766 I-pregnancy
( 330 331 767 768 I-pregnancy
β 331 332 768 769 I-pregnancy
- 332 333 769 770 I-pregnancy
HCG 333 336 770 773 I-pregnancy
) 336 337 773 774 I-pregnancy
pregnancy 338 347 775 784 I-pregnancy
test 348 352 785 789 O
within 353 359 790 796 O
14 360 362 797 799 B-upper_bound
days 363 367 800 804 I-upper_bound
prior 368 373 805 810 I-upper_bound
to 374 376 811 813 O
the 377 380 814 817 O
first 381 386 818 823 O
day 387 390 824 827 O
of 391 393 828 830 O
study 394 399 831 836 O
treatment 400 409 837 846 O

Male 0 4 847 851 B-gender
patients 5 13 852 860 I-gender
are 14 17 861 864 O
to 18 20 865 867 O
agree 21 26 868 873 B-contraception_consent
to 27 29 874 876 I-contraception_consent
use 30 33 877 880 I-contraception_consent
a 34 35 881 882 I-contraception_consent
barrier 36 43 883 890 I-contraception_consent
method 44 50 891 897 I-contraception_consent
of 51 53 898 900 I-contraception_consent
contraception 54 67 901 914 I-contraception_consent
from 68 72 915 919 O
study 73 78 920 925 O
treatment 79 88 926 935 B-treatment
initiation 89 99 936 946 O
until 100 105 947 952 O
at 106 108 953 955 O
least 109 114 956 961 O
90 115 117 962 964 B-lower_bound
days 118 122 965 969 I-lower_bound
after 123 128 970 975 O
the 129 132 976 979 O
last 133 137 980 984 O
administration 138 152 985 999 O
of 153 155 1000 1002 O
Folotyn 156 163 1003 1010 O

Platelet 0 8 1011 1019 B-clinical_variable
count 9 14 1020 1025 I-clinical_variable
≥100,000/µL 15 26 1026 1037 O

Total 0 5 1038 1043 B-clinical_variable
bilirubin 6 15 1044 1053 I-clinical_variable
≤1.5 16 20 1054 1058 O
mg 21 23 1059 1061 I-upper_bound
/ 23 24 1061 1062 I-upper_bound
dL 24 26 1062 1064 I-upper_bound

active 0 6 1065 1071 B-chronic_disease
uncontrolled 7 19 1072 1084 I-chronic_disease
infection 20 29 1085 1094 I-chronic_disease
, 29 30 1094 1095 O
underlying 31 41 1096 1106 O
medical 42 49 1107 1114 B-chronic_disease
condition 50 59 1115 1124 I-chronic_disease
, 59 60 1124 1125 O
or 61 63 1126 1128 O
other 64 69 1129 1134 O
serious 70 77 1135 1142 B-chronic_disease
illness 78 85 1143 1150 I-chronic_disease
that 86 90 1151 1155 O
would 91 96 1156 1161 O
impair 97 103 1162 1168 O
the 104 107 1169 1172 O
ability 108 115 1173 1180 O
of 116 118 1181 1183 O
the 119 122 1184 1187 O
patient 123 130 1188 1195 O
to 131 133 1196 1198 O
receive 134 141 1199 1206 O
protocol 142 150 1207 1215 O
treatment 151 160 1216 1225 B-treatment

at 0 2 1226 1228 O
least 3 8 1229 1234 O
18 9 11 1235 1237 B-lower_bound
years 12 17 1238 1243 I-lower_bound
of 18 20 1244 1246 O
age 21 24 1247 1250 B-age

congestive 0 10 1251 1261 B-chronic_disease
heart 11 16 1262 1267 I-chronic_disease
failure 17 24 1268 1275 I-chronic_disease
Class 25 30 1276 1281 B-lower_bound
III 31 34 1282 1285 I-lower_bound
/ 34 35 1285 1286 O
IV 35 37 1286 1288 B-upper_bound
according 38 47 1289 1298 O
to 48 50 1299 1301 O
the 51 54 1302 1305 O
New 55 58 1306 1309 B-clinical_variable
York 59 63 1310 1314 I-clinical_variable
Heart 64 69 1315 1320 I-clinical_variable
Association 70 81 1321 1332 I-clinical_variable
( 82 83 1333 1334 I-clinical_variable
NYHA 83 87 1334 1338 I-clinical_variable
) 87 88 1338 1339 I-clinical_variable
Functional 89 99 1340 1350 I-clinical_variable
Classification 100 114 1351 1365 I-clinical_variable

diagnosed 0 9 1366 1375 O
with 10 14 1376 1380 O
hematological 15 28 1381 1394 B-cancer
malignancies 29 41 1395 1407 I-cancer
including 42 51 1408 1417 O
PTCL 52 56 1418 1422 B-chronic_disease
and 57 60 1423 1426 O
CTCL 61 65 1427 1431 B-cancer
and 66 69 1432 1435 O
are 70 73 1436 1439 O
eligible 74 82 1440 1448 O
for 83 86 1449 1452 O
treatment 87 96 1453 1462 B-treatment
with 97 101 1463 1467 O
a 102 103 1468 1469 O
dose 104 108 1470 1474 O
of 109 111 1475 1477 O
30 112 114 1478 1480 O
mg 115 117 1481 1483 O
/ 117 118 1483 1484 O
m^2 118 121 1484 1487 O

had 0 3 1488 1491 O
major 4 9 1492 1497 B-treatment
surgery 10 17 1498 1505 I-treatment
within 18 24 1506 1512 O
14 25 27 1513 1515 B-upper_bound
days 28 32 1516 1520 I-upper_bound
prior 33 38 1521 1526 I-upper_bound
to 39 41 1527 1529 O
enrollment 42 52 1530 1540 O

had 0 3 1541 1544 O
previous 4 12 1545 1553 O
exposure 13 21 1554 1562 O
to 22 24 1563 1565 O
Folotyn 25 32 1566 1573 B-treatment
within 33 39 1574 1580 O
6 40 41 1581 1582 B-upper_bound
months 42 48 1583 1589 I-upper_bound
of 49 51 1590 1592 O
study 52 57 1593 1598 O
enrollment 58 68 1599 1609 O

has 0 3 1610 1613 O
recovered 4 13 1614 1623 O
from 14 18 1624 1628 O
the 19 22 1629 1632 O
toxic 23 28 1633 1638 O
effects 29 36 1639 1646 O
of 37 39 1647 1649 O
prior 40 45 1650 1655 O
therapy 46 53 1656 1663 B-treatment
, 53 54 1663 1664 O
and 55 58 1665 1668 O
is 59 61 1669 1671 O
at 62 64 1672 1674 O
least 65 70 1675 1680 O
30 71 73 1681 1683 B-lower_bound
days 74 78 1684 1688 I-lower_bound
from 79 83 1689 1693 O
the 84 87 1694 1697 O
most 88 92 1698 1702 O
recent 93 99 1703 1709 O
cytotoxic 100 109 1710 1719 B-treatment
therapy 110 117 1720 1727 I-treatment
, 117 118 1727 1728 O
prior 119 124 1729 1734 O
to 125 127 1735 1737 O
enrollment 128 138 1738 1748 O

known 0 5 1749 1754 O
, 5 6 1754 1755 O
uncontrolled 7 19 1756 1768 O
human 20 25 1769 1774 B-chronic_disease
immunodeficiency 26 42 1775 1791 I-chronic_disease
virus 43 48 1792 1797 I-chronic_disease
( 49 50 1798 1799 I-chronic_disease
HIV)-positive 50 63 1799 1812 I-chronic_disease
diagnosis 64 73 1813 1822 O

pregnant 0 8 1823 1831 B-pregnancy

received 0 8 1832 1840 O
prophylactic 9 21 1841 1853 B-treatment
CNS 22 25 1854 1857 I-treatment
treatment 26 35 1858 1867 I-treatment
are 36 39 1868 1871 O
eligible 40 48 1872 1880 O

symptomatic 0 11 1881 1892 O
central 12 19 1893 1900 B-cancer
nervous 20 27 1901 1908 I-cancer
system 28 34 1909 1915 I-cancer
( 35 36 1916 1917 I-cancer
CNS 36 39 1917 1920 I-cancer
) 39 40 1920 1921 I-cancer
metastases 41 51 1922 1932 I-cancer
or 52 54 1933 1935 O
lesions 55 62 1936 1943 O
for 63 66 1944 1947 O
which 67 72 1948 1953 O
treatment 73 82 1954 1963 B-treatment
is 83 85 1964 1966 O
required 86 94 1967 1975 O

uncontrolled 0 12 1976 1988 O
hypertension 13 25 1989 2001 B-chronic_disease

used 0 4 2002 2006 O
any 5 8 2007 2010 O
investigational 9 24 2011 2026 B-treatment
drugs 25 30 2027 2032 I-treatment
, 30 31 2032 2033 O
biologics 32 41 2034 2043 B-treatment
, 41 42 2043 2044 O
or 43 45 2045 2047 O
devices 46 53 2048 2055 B-treatment
within 54 60 2056 2062 O
14 61 63 2063 2065 B-upper_bound
days 64 68 2066 2070 I-upper_bound
prior 69 74 2071 2076 I-upper_bound
to 75 77 2077 2079 O
study 78 83 2080 2085 O
treatment 84 93 2086 2095 B-treatment
or 94 96 2096 2098 O
plans 97 102 2099 2104 O
to 103 105 2105 2107 O
use 106 109 2108 2111 O
any 110 113 2112 2115 O
of 114 116 2116 2118 O
these 117 122 2119 2124 O
during 123 129 2125 2131 O
the 130 133 2132 2135 O
course 134 140 2136 2142 O
of 141 143 2143 2145 O
the 144 147 2146 2149 O
study 148 153 2150 2155 O

